Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

A Transcription Factor Feedback Loop Controls Early Placenta Development

By BiotechDaily International staff writers
Posted on 30 Apr 2013
The molecular pathways leading to development of the placenta are regulated by a feedback loop between the transcription factors Gcm1 (chorion-specific transcription factor or hGCMa), which is a mammalian homologue of the Drosophila GCM (glia cells missing) and Fzd5 (Frizzled5).

Abnormal placental development during pregnancy is associated with conditions such as preeclampsia, intrauterine growth restriction, and even fetal death in humans. Investigators at the Chinese Academy of Sciences (Beijing) worked with a mouse model of placental development that closely mimicked the process in humans. They focused on the earliest steps of placenta formation, which involves the development of the labyrinthine layer, a specialized epithelium that sits between the maternal blood and fetal blood vessels and facilitates the exchange of nutrients, gases, and wastes between the mother and fetus. Pivotal to the development of a functional labyrinth layer are the processes of folding and branching of a flat sheet of trophoblast cells (originally the outer layer of the blastocyst), and of trophoblast cell differentiation.

Results published in the April 16, 2013, online edition of the journal PLOS Biology revealed that in mice Fzd5, a receptor component of the Wnt signaling pathway, and Gcm1, an important transcription factor for labyrinth development, formed a positive feedback loop that directed normal placental development. Gcm1 up-regulated Fzd5 specifically at branching sites, and elevated Fzd5 expression in turn maintained expression of Gcm1.

Fzd5-mediated signaling was required for the disassociation of cell junctions and for the up-regulation of VEGF (vascular endothelial growth factor) expression in trophoblast cells. Furthermore, the FZD5-GCM1 signaling cascade was found to operate in primary cultures of human trophoblasts undergoing differentiation.

"We provide here genetic, molecular, pharmacological, and physiological evidence that an amplifying feedback loop between Gcm1 and Fzd5 is essential for normal placental development of mice," said senior author Dr. Haibin Wang, professor of developmental biology at the Chinese Academy of Sciences. "Besides shedding light on the fundamental mechanisms of branching morphogenesis during mouse placental development, the finding has high clinical relevance, since the Gcm1-Fzd5 signaling cascade also operates in human trophoblasts, and when its regulation goes wrong, it can be linked to trophoblast-related diseases, such as preeclampsia."

Related Links:
Chinese Academy of Sciences


comments powered by Disqus

Channels

Drug Discovery

view channel
Image: The new peptide offers a triple hormone effect in a single-cell molecule (Photo courtesy of Indiana University).

Tripeptide Drug Effectively Controls Metabolic Syndrome in Rodent Model

Promising results in reducing obesity and normalizing glucose metabolism obtained with a synthetic dipeptide drug have been enhanced by the addition of a molecule of a third hormone, glucagon.... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.